These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 14556550)

  • 1. [Combination therapy of chronic pancreatitis (double-blind, placebo-controlled, pilot studies)].
    Starostin BD
    Eksp Klin Gastroenterol; 2003; (3):58-65. PubMed ID: 14556550
    [No Abstract]   [Full Text] [Related]  

  • 2. [Assessment of efficacy and safety of two modes of maintenance therapy with rabeprazole in patients with gastroesophageal reflux disease (GERD) of degrees 0 and 1].
    Minushkin ON; Maslovskiĭ LV; Anikina NIu; Shuleshova AG
    Eksp Klin Gastroenterol; 2005; (2):29-35. PubMed ID: 15932152
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical aspects of using pariet in treating chronic pancreatitis].
    Sablin OA; Ratnikov VA; Butenko EV; Pakhomova IG
    Eksp Klin Gastroenterol; 2002; (5):73-6, 129. PubMed ID: 12619583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Modern means of anti-Helicobacter therapy].
    Starostin BD
    Voen Med Zh; 2001 Oct; 322(10):58-63. PubMed ID: 11764485
    [No Abstract]   [Full Text] [Related]  

  • 5. [Particular features of application of proton pump inhibitors (Rabeprazole) in children with the gastroesophageal reflux disease].
    Khavkin AI; Zhikhareva NS; Rachkova NS; Babaian ML; Volynets GV; Khanakaeva ZK
    Eksp Klin Gastroenterol; 2004; (2):53-6. PubMed ID: 15462323
    [No Abstract]   [Full Text] [Related]  

  • 6. [Safety profile of pariet clinical use (a literature review)].
    Sheptulin AA
    Voen Med Zh; 2001 May; 322(5):35-40. PubMed ID: 11550328
    [No Abstract]   [Full Text] [Related]  

  • 7. A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough.
    Ours TM; Kavuru MS; Schilz RJ; Richter JE
    Am J Gastroenterol; 1999 Nov; 94(11):3131-8. PubMed ID: 10566703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose rabeprazole, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese patients.
    Wong WM; Huang J; Xia HH; Fung FM; Tong TS; Cheung KL; Ho VY; Lai KC; Chan CK; Chan AO; Hui CK; Lam SK; Wong BC
    J Gastroenterol Hepatol; 2005 Jun; 20(6):935-40. PubMed ID: 15946144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Regeneration of the gastric epitheliocytes during treatment of duodenal ulcer with pariet].
    Kulidzhanov AIu; Usik SF; Osadchuk MA; Kvetnoĭ IM; Kheĭlyk AI
    Voen Med Zh; 2002 Apr; 323(4):38-42. PubMed ID: 12046531
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration.
    Stack WA; Knifton A; Thirlwell D; Cockayne A; Jenkins D; Hawkey CJ; Atherton JC
    Am J Gastroenterol; 1998 Oct; 93(10):1909-13. PubMed ID: 9772054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Proton pump inhibitor-based quadruple therapy regimen for Helicobacter pylori infection].
    Ohkusa T; Sato N
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():431-4. PubMed ID: 11979821
    [No Abstract]   [Full Text] [Related]  

  • 12. Rabeprazole: pharmacokinetics in patients with stable, compensated cirrhosis.
    Hoyumpa AM; Trevino-Alanis H; Grimes I; Humphries TJ
    Clin Ther; 1999 Apr; 21(4):691-701. PubMed ID: 10363734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review article: efficacy and safety of rabeprazole in treating gastroesophageal reflux disease.
    Lim PW; Goh KL
    J Gastroenterol Hepatol; 2004 Sep; 19 Suppl 3():S61-8. PubMed ID: 15324384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restorative impact of rabeprazole on gastric mucus and mucin production impairment during naproxen administration: its potential clinical significance.
    Jaworski T; Sarosiek I; Sostarich S; Roeser K; Connor M; Brotze S; Wallner G; Sarosiek J
    Dig Dis Sci; 2005 Feb; 50(2):357-65. PubMed ID: 15745101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton pump inhibitor therapy for chronic laryngo-pharyngitis: a randomized placebo-control trial.
    Steward DL; Wilson KM; Kelly DH; Patil MS; Schwartzbauer HR; Long JD; Welge JA
    Otolaryngol Head Neck Surg; 2004 Oct; 131(4):342-50. PubMed ID: 15467597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Some comparative aspects of treating the gastroesophageal reflux disease eradication].
    Minushkin ON; Maslovskiĭ LV; Anikina NIu
    Eksp Klin Gastroenterol; 2004; (3):45-8, 104. PubMed ID: 15560401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rabeprazole for the prevention of pathologic and symptomatic relapse of erosive or ulcerative gastroesophageal reflux disease. Rebeprazole Study Group.
    Caos A; Moskovitz M; Dayal Y; Perdomo C; Niecestro R; Barth J
    Am J Gastroenterol; 2000 Nov; 95(11):3081-8. PubMed ID: 11095321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rabeprazole in nonerosive gastroesophageal reflux disease: a randomized placebo-controlled trial.
    Miner P; Orr W; Filippone J; Jokubaitis L; Sloan S
    Am J Gastroenterol; 2002 Jun; 97(6):1332-9. PubMed ID: 12094846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rabeprazole containing triple therapy to eradicate Helicobacter pylori infection on the Texas-Mexican border.
    Cardenas VM; Graham DY; El-Zimaity HM; Opekun AR; Campos A; Chavez A; Guerrero L
    Aliment Pharmacol Ther; 2006 Jan; 23(2):295-301. PubMed ID: 16393310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oral cavity manifestations of gastroesophageal reflux disease].
    Maev IV; Barer GM; Busarova GA; Pustovoĭt EV; Polikanova EN; Burkov SG; Gurenev GL
    Klin Med (Mosk); 2005; 83(11):33-8. PubMed ID: 16404937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.